Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...

Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

Regenxbio and AbbVie announced positive Phase II results for gene therapy ABBV-RGX-314 in wet AMD, showing a 97% reduction in ...

Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining the price ...

The most pressing challenges include the financial and emotional burdens associated with frequent, long-term treatments for ...

Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...

called the results a “milestone” in treating severe vision loss caused by age-related macular degeneration. “Prior to this, there have been no real treatment options to improve vision for ...

Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...

today announced accelerated timelines for the SOL-1 Phase 3 registrational clinical trial of AXPAXLI in wet age-related ...

About Genentech in Ophthalmology Genentech is researching and developing new treatments for people living with a range of eye ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration ... drugs available for people with "wet" AMD, in which leaking blood vessels damage the ...